DE69535554D1 - Lumineszente lanthanidenchelate und verfahren zu ihrer verwendung - Google Patents

Lumineszente lanthanidenchelate und verfahren zu ihrer verwendung

Info

Publication number
DE69535554D1
DE69535554D1 DE69535554T DE69535554T DE69535554D1 DE 69535554 D1 DE69535554 D1 DE 69535554D1 DE 69535554 T DE69535554 T DE 69535554T DE 69535554 T DE69535554 T DE 69535554T DE 69535554 D1 DE69535554 D1 DE 69535554D1
Authority
DE
Germany
Prior art keywords
lanthanideschelates
luminescent
luminescent lanthanideschelates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69535554T
Other languages
English (en)
Other versions
DE69535554T2 (de
Inventor
Paul R Selvin
John Hearst
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California
Original Assignee
University of California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California filed Critical University of California
Application granted granted Critical
Publication of DE69535554D1 publication Critical patent/DE69535554D1/de
Publication of DE69535554T2 publication Critical patent/DE69535554T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G01N33/533—Production of labelled immunochemicals with fluorescent label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/80—Fluorescent dyes, e.g. rhodamine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/805—Optical property
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/13—Tracers or tags
DE69535554T 1994-06-29 1995-06-29 Lumineszente lanthanidenchelate und verfahren zu ihrer verwendung Expired - Lifetime DE69535554T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US269162 1994-06-29
US08/269,162 US5622821A (en) 1994-06-29 1994-06-29 Luminescent lanthanide chelates and methods of use
PCT/US1995/008319 WO1996000901A1 (en) 1994-06-29 1995-06-29 Luminescent lanthanide chelates and methods of use

Publications (2)

Publication Number Publication Date
DE69535554D1 true DE69535554D1 (de) 2007-09-20
DE69535554T2 DE69535554T2 (de) 2008-04-30

Family

ID=23026062

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69535554T Expired - Lifetime DE69535554T2 (de) 1994-06-29 1995-06-29 Lumineszente lanthanidenchelate und verfahren zu ihrer verwendung

Country Status (8)

Country Link
US (3) US5622821A (de)
EP (1) EP0767912B1 (de)
JP (1) JP3814291B2 (de)
AU (1) AU688928B2 (de)
CA (1) CA2193501C (de)
DE (1) DE69535554T2 (de)
ES (1) ES2290953T3 (de)
WO (1) WO1996000901A1 (de)

Families Citing this family (145)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7081226B1 (en) 1996-06-04 2006-07-25 University Of Utah Research Foundation System and method for fluorescence monitoring
US7273749B1 (en) 1990-06-04 2007-09-25 University Of Utah Research Foundation Container for carrying out and monitoring biological processes
US5605798A (en) 1993-01-07 1997-02-25 Sequenom, Inc. DNA diagnostic based on mass spectrometry
US5925517A (en) * 1993-11-12 1999-07-20 The Public Health Research Institute Of The City Of New York, Inc. Detectably labeled dual conformation oligonucleotide probes, assays and kits
US5620850A (en) 1994-09-26 1997-04-15 President And Fellows Of Harvard College Molecular recognition at surfaces derivatized with self-assembled monolayers
US6770261B2 (en) * 1995-06-02 2004-08-03 Research Corporation Technologies Magnetic resonance imaging agents for the detection of physiological agents
AU2069597A (en) * 1996-03-04 1997-09-22 Genetrace Systems, Inc. Methods of screening nucleic acids using mass spectrometry
US5928955A (en) * 1996-03-22 1999-07-27 California Institute Of Technology Peptidyl fluorescent chemosensor for divalent zinc
WO1998010096A1 (en) * 1996-04-12 1998-03-12 The Public Health Research Institute Of The City Of New York, Inc. Detection probes, kits and assays
CA2252048C (en) * 1996-04-12 2008-03-11 The Public Health Research Institute Of The City Of New York, Inc. Detection probes, kits and assays
EP1179600B1 (de) * 1996-06-04 2005-05-11 University Of Utah Research Foundation Überwachung der Hybridisierung während PCR
ES2215230T3 (es) * 1996-06-04 2004-10-01 University Of Utah Research Foundation Sistema y metodo para llevar a cabo y supervisar reacciones de cadena de polimerasa.
US5900228A (en) 1996-07-31 1999-05-04 California Institute Of Technology Bifunctional detection agents having a polymer covalently linked to an MRI agent and an optical dye
FI963989A (fi) * 1996-10-04 1998-04-05 Wallac Oy Homogeenisiä määritysmenetelmiä, jotka perustuvat luminesenssienergiasiirtoon
US7014992B1 (en) 1996-11-05 2006-03-21 Clinical Micro Sensors, Inc. Conductive oligomers attached to electrodes and nucleoside analogs
EP1164203B1 (de) * 1996-11-06 2007-10-10 Sequenom, Inc. DNA-Diagnostik mittels Massenspektrometrie
US6027709A (en) * 1997-01-10 2000-02-22 Li-Cor Inc. Fluorescent cyanine dyes
US6306584B1 (en) * 1997-01-21 2001-10-23 President And Fellows Of Harvard College Electronic-property probing of biological molecules at surfaces
EP0968424A1 (de) * 1997-03-03 2000-01-05 Akzo Nobel N.V. Ion-ligand komplexe auf neodym (iii), ytterbium (iii) oder erbium (iii) in der diagnostik
US6951760B2 (en) 1997-03-03 2005-10-04 Johannes Willem Hofstraat Diagnostic neodymium(III), ytterbium(III), or erbium(III) ion-ligand complexes
US7745142B2 (en) * 1997-09-15 2010-06-29 Molecular Devices Corporation Molecular modification assays
US20050227294A1 (en) * 1997-09-15 2005-10-13 Molecular Devices Corporation Molecular modification assays involving lipids
US7632651B2 (en) * 1997-09-15 2009-12-15 Mds Analytical Technologies (Us) Inc. Molecular modification assays
FR2768817B1 (fr) 1997-09-19 1999-12-10 Cis Bio Int Methode homogene pour la detection et/ou la determination de l'activite phosphorylante d'un materiel biologique
US6297018B1 (en) 1998-04-17 2001-10-02 Ljl Biosystems, Inc. Methods and apparatus for detecting nucleic acid polymorphisms
US6133429A (en) * 1997-10-03 2000-10-17 Becton Dickinson And Company Chromophores useful for the preparation of novel tandem conjugates
US6713046B1 (en) 1997-10-27 2004-03-30 Research Corporation Technologies Magnetic resonance imaging agents for the delivery of therapeutic agents
JP4163381B2 (ja) 1997-11-17 2008-10-08 カリフォルニア・インスティテュート・オブ・テクノロジー 生理学的薬剤の検出のための磁気共鳴造影剤
US6713256B1 (en) * 1998-02-14 2004-03-30 Fraunhofer Gesellschaft zur Förderung der angewandten Forschung e.V. Fluorescent energy transfer mediated chemical activation (fetma) for the elucidation of the three-dimensional structure of biomacromolecules
US6749811B2 (en) * 1998-04-28 2004-06-15 The Johns Hopkins University Molecularly imprinted polymer solution anion sensor
US7416703B2 (en) * 1998-04-28 2008-08-26 The Johns Hopkins University Polymer based lanthanide luminescent sensors for the detection of organophosphorus compounds
GB9811483D0 (en) * 1998-05-29 1998-07-29 Photonic Research Systems Limi Luminescence assay using cyclical excitation wavelength sequence
US6030840A (en) * 1998-06-15 2000-02-29 Nen Life Sciences, Inc. Neutral enhancement of lanthanides for time resolved fluorescence
US7087148B1 (en) 1998-06-23 2006-08-08 Clinical Micro Sensors, Inc. Binding acceleration techniques for the detection of analytes
GB9813776D0 (en) * 1998-06-25 1998-08-26 Smithkline Beecham Plc Novel compounds
US6740756B1 (en) 1998-07-07 2004-05-25 Smithkline Beecham Corporation Fluorescent lanthanide chelates
EP1095011A4 (de) * 1998-07-07 2003-01-08 Smithkline Beecham Corp Neue fluoreszierende lanthanid-chelate
US5998146A (en) * 1998-07-17 1999-12-07 Wallac Oy Homogeneous luminescence assay method based on energy transfer
US6037130A (en) * 1998-07-28 2000-03-14 The Public Health Institute Of The City Of New York, Inc. Wavelength-shifting probes and primers and their use in assays and kits
US6740518B1 (en) 1998-09-17 2004-05-25 Clinical Micro Sensors, Inc. Signal detection techniques for the detection of analytes
DE19964220C2 (de) 1998-11-23 2003-07-03 Friz Biochem Gmbh Verfahren zur Herstellung einer modifizierten leitfähigen Oberfläche
WO2000034522A2 (en) * 1998-12-11 2000-06-15 Pall Corporation Detection of biomaterial
US6511649B1 (en) * 1998-12-18 2003-01-28 Thomas D. Harris Vitronectin receptor antagonist pharmaceuticals
FR2788523B1 (fr) * 1999-01-18 2001-02-16 Commissariat Energie Atomique Derives de calixarenes, leur procede de preparation et leur utilisation pour l'extraction des actinides et des lanthanides
DE19901761A1 (de) * 1999-01-18 1999-07-01 Gerhard Dr Hartwich Verfahren zur elektrochemischen Detektion von Nukleinsäure-Oligomer-Hybridisierungsereignissen
CA2371816C (en) * 1999-02-18 2010-04-27 The Regents Of The University Of California Phthalamide-lanthanide complexes for use as luminescent markers
US6838292B1 (en) * 1999-04-19 2005-01-04 Alion Science And Technology Corporation Detection of biological warfare agents
US7312087B2 (en) 2000-01-11 2007-12-25 Clinical Micro Sensors, Inc. Devices and methods for biochip multiplexing
US20020177135A1 (en) * 1999-07-27 2002-11-28 Doung Hau H. Devices and methods for biochip multiplexing
AT407876B (de) 1999-04-30 2001-07-25 Georg Dr Uray Lumineszierende 4-trifluormethyl-2-chinolinone mit langwelliger uv-absorption und ihre verwendung
US6410255B1 (en) * 1999-05-05 2002-06-25 Aurora Biosciences Corporation Optical probes and assays
US6402986B1 (en) 1999-07-16 2002-06-11 The Trustees Of Boston University Compositions and methods for luminescence lifetime comparison
US6667179B1 (en) * 1999-10-28 2003-12-23 The Board Of Trustees Of The University Of Illinois Semiconductor luminescence quenchers for detecting proximal molecular binding events
US7332344B2 (en) * 1999-12-01 2008-02-19 Photonic Research Systems Limited Luminescence assays
US20020072625A1 (en) * 1999-12-10 2002-06-13 Johnson David Kenneth Materials and methods for measuring chelate: anti-chelate binding by fluorescence polarization immunoassay
WO2001055702A1 (en) * 2000-01-31 2001-08-02 Board Of Regents, The University Of Texas System Portable sensor array system
CN1222767C (zh) * 2000-02-28 2005-10-12 第一化学药品株式会社 荧光测定试样中测定对象物质的测定方法以及用于该方法的试剂组合物和试剂盒
US6528318B1 (en) * 2000-03-06 2003-03-04 The Johns Hopkins University Scatter controlled emission for optical taggants and chemical sensors
US6673333B1 (en) 2000-05-04 2004-01-06 Research Corporation Technologies, Inc. Functional MRI agents for cancer imaging
US20040146463A1 (en) * 2000-05-04 2004-07-29 Meade Thomas J. Functional MRI agents for cancer imaging
JP4382265B2 (ja) * 2000-07-12 2009-12-09 日本電気株式会社 酸化シリコン膜の形成方法及びその形成装置
US6656450B2 (en) 2000-07-17 2003-12-02 California Institute Of Technology, Inc. Macrocyclic magnetic resonance imaging contrast agents
US6440389B1 (en) * 2000-07-19 2002-08-27 The General Hospital Corporation Fluorescent agents for real-time measurement of organ function
US7198924B2 (en) 2000-12-11 2007-04-03 Invitrogen Corporation Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites
AU2002211517A1 (en) 2000-10-04 2002-04-15 California Institute Of Technology Magnetic resonance imaging agents for in vivo labeling and detection of amyloid deposits
WO2002041001A1 (de) * 2000-11-16 2002-05-23 Roche Diagnostics Gmbh Farbstoffpaare für fluoreszenz-resonanz-energie-transfer (fret) messungen
US20030004236A1 (en) * 2001-04-20 2003-01-02 Meade Thomas J. Magnetic resonance imaging agents for detection and delivery of therapeutic agents and detection of physiological substances
US20020197648A1 (en) * 2001-05-02 2002-12-26 Silva Robin M. High throughput screening methods using magnetic resonance imaging agents
GB0113435D0 (en) * 2001-06-04 2001-07-25 Amersham Pharm Biotech Uk Ltd Acridone derivatives as labels for fluorescence detection of target materials
EP1412749A4 (de) * 2001-06-28 2006-12-13 Ia Inc Faseroptisches sensorarray
WO2003020701A2 (en) * 2001-09-04 2003-03-13 Texas Tech University Multi-use multimodal imaging chelates
DE10153829A1 (de) 2001-11-05 2003-05-28 Bayer Ag Assay basierend auf dotierten Nanoteilchen
CA2482767A1 (en) * 2002-04-22 2003-10-30 Joseph F. Lawler, Jr. Reagents for monitoring nuclei acid amplification and methods of using same
JP4206378B2 (ja) * 2002-07-08 2009-01-07 哲雄 長野 蛍光プローブ
WO2004040296A1 (ja) * 2002-10-16 2004-05-13 Daiichi Pure Chemicals Co., Ltd. パーオキシナイトライト測定用試薬
US7696245B2 (en) * 2003-03-28 2010-04-13 Sekisui Medical Co., Ltd. Fluorescent probe for zinc
US7619059B2 (en) * 2003-07-29 2009-11-17 Life Technologies Corporation Bimolecular optical probes
CA2445420A1 (en) 2003-07-29 2005-01-29 Invitrogen Corporation Kinase and phosphatase assays
US7727752B2 (en) * 2003-07-29 2010-06-01 Life Technologies Corporation Kinase and phosphatase assays
EP2484687A3 (de) 2003-08-08 2012-11-14 Life Technologies Corporation Verfahren und Zusammensetzungen zum nahtlosen Klonieren von Nukleinsäuremolekülen
DE602004025592D1 (de) * 2003-09-12 2010-04-01 Life Technologies Corp Anwendungen des Resonanzenergietransfers zwischen Terbium und GFP
CN1886661B (zh) * 2003-10-01 2010-06-02 沃拉克有限公司 改进的均匀时间分辨能量转移测定
EP1697534B1 (de) 2003-12-01 2010-06-02 Life Technologies Corporation Rekombinationsstellen enthaltende nukleinsäuremoleküle und verfahren zur verwendung davon
JP2005194244A (ja) * 2004-01-09 2005-07-21 Shigenobu Yano 亜鉛イオン蛍光センサー
ES2380623T3 (es) * 2004-04-08 2012-05-16 The Johns-Hopkins University Polímeros molecularmente impresos procesables
CA2581639C (en) 2004-09-30 2016-07-26 Molecular Devices Corporation Luminescent lanthanide complexes
US20060147954A1 (en) * 2004-10-19 2006-07-06 Wallac Oy Novel probe and its use in bioaffinity assays
US20060115842A1 (en) * 2004-10-22 2006-06-01 Wallac Oy Highly sensitive homogeneous assay based on anti-Stokes' shift FRET measurement
US20060171845A1 (en) * 2005-01-31 2006-08-03 Dakota Technologies, Inc. Sensors for measuring analytes
US8193174B2 (en) * 2005-05-11 2012-06-05 University Of Durham Responsive luminescent lanthanide complexes
EP2703499A1 (de) * 2005-06-02 2014-03-05 Fluidigm Corporation Analyse unter Verwendung einer mikrofluidischen Aufteilungsvorrichtung zur Bereitstellung von Einzelzellproben
WO2007051207A2 (en) 2005-10-28 2007-05-03 Invitrogen Corporation Kinase and ubiquination assays
US8110404B2 (en) * 2005-11-14 2012-02-07 Board Of Trustees Of The University Of Illinois Luminescent lanthanide binding chelates
EP2056709A4 (de) * 2006-08-11 2013-05-01 Univ New Jersey Med Zweifachsensibilisator mit lumineszenzverbindungen, konjugaten und verwendung
AU2007323920B2 (en) * 2006-11-13 2013-09-19 Perkinelmer Health Sciences, Inc. Detecting molecular interactions
WO2008124834A1 (en) * 2007-04-10 2008-10-16 Stanford University Photoacoustic probes and methods of imaging
GB0805608D0 (en) * 2008-03-28 2008-04-30 Sec Dep For Environment Food & Detection method
US8889839B2 (en) * 2008-05-07 2014-11-18 Syracuse University Pyridine-bis (oxazoline)(“pybox”) moiety as a chelator and sensitizer for lanthanide ion (Ln (III)) Luminescence
FR2934684B1 (fr) 2008-07-31 2012-11-16 Cis Bio Int Methode de detection de l'internalisation de proteines membranaires.
US7857900B2 (en) * 2008-09-19 2010-12-28 Xerox Corporation Solid phase change fluorescent ink and ink sets
DE102009000813A1 (de) 2009-02-12 2010-08-19 Evonik Degussa Gmbh Fluoreszenzkonversionssolarzelle I Herstellung im Plattengußverfahren
FI20090100A0 (fi) 2009-03-16 2009-03-16 Wallac Oy Biotinidaasimääritys
DE102009002386A1 (de) 2009-04-15 2010-10-21 Evonik Degussa Gmbh Fluoreszenzkonversionssolarzelle - Herstellung im Spritzgussverfahren
CA2759885A1 (fr) 2009-04-30 2010-11-04 Etienne Doumazane Procede de detection de composes modulateurs de dimeres de proteines membranaires a domaine vft
DE102009027431A1 (de) 2009-07-02 2011-01-05 Evonik Degussa Gmbh Fluoreszenzkonversionssolarzelle - Herstellung im Extrusionsverfahren oder im Coextrusionsverfahren
FR2949156B1 (fr) 2009-08-13 2016-04-15 Cis-Bio Int Methode de determination de la liaison d'un compose donne a un recepteur membranaire
GB0915986D0 (en) 2009-09-14 2009-10-28 Sec Dep For Environment Food A Detection method
CN102549438B (zh) 2009-09-24 2014-10-29 国家健康与医学研究院 Fkbp52-tau相互作用作为新颖治疗靶点用于治疗涉及tau机能失调的神经障碍
EP2494404B1 (de) * 2009-10-28 2014-12-10 Hewlett-Packard Development Company, L.P. Einschichtige reflektierende anzeige mit lumineszenz
US9221759B2 (en) * 2010-01-13 2015-12-29 Rutgers, The State University Of New Jersey Fluorophore chelated lanthanide luminescent probes with improved quantum efficiency
DE102010028180A1 (de) 2010-04-26 2011-10-27 Evonik Röhm Gmbh Fluoreszenzkonversionssolarzelle - Herstellung im Extrusionslaminationsverfahren oder im Kleberlaminationsverfahren
DE102010028186A1 (de) 2010-04-26 2011-10-27 Evonik Röhm Gmbh Fluoreszenzkonversionssolarzelle Lacke
DE102010038685A1 (de) 2010-07-30 2012-02-02 Evonik Röhm Gmbh Fluoreszenzkonversionssolarzelle Herstellung im Plattengußverfahren
GB2482423A (en) * 2010-07-31 2012-02-01 Advanced Biomedical Ltd A method for determining the effectiveness of a sterilization or disinfection process
US8778614B2 (en) 2010-08-24 2014-07-15 Enzo Life Sciences, Inc. Assays for detecting modified compounds
GB201018361D0 (en) 2010-11-01 2010-12-15 Thompson Edward J Fluorometry
DE102011001368B4 (de) * 2011-03-17 2013-01-31 Bundesanstalt für Materialforschung und -Prüfung (BAM) Lanthanoid-Chelate enthaltende Partikel, deren Herstellung sowie deren Verwendung in der Bioanalytik
FR2977674B1 (fr) 2011-07-06 2015-08-14 Cisbio Bioassays Methode amelioree de detection et/ou de quantification d'un analyte present a la surface d'une cellule
FR2978149B1 (fr) 2011-07-18 2014-01-10 Cisbio Bioassays Nouveaux agents complexants et complexes de lanthanide correspondant, et leur utilisation comme marqueurs luminescents
FR2980271B1 (fr) 2011-09-16 2013-10-11 Cisbio Bioassays Procede de determination de la glycosylation d'un anticorps
US20150185150A1 (en) 2012-02-22 2015-07-02 Cisbio Bioassays Method for normalizing the luminescence emitted by a measuring medium
FR2988174B1 (fr) 2012-03-19 2014-04-25 Cisbio Bioassays Procede de determination de la capacite d'un anticorps a maintenir des cellules a proximite l'une de l'autre
SG11201407901PA (en) 2012-05-21 2015-01-29 Fluidigm Corp Single-particle analysis of particle populations
WO2013188927A1 (en) 2012-06-22 2013-12-27 Macquarie University Multiplex suspension assay/array using lifetime coding
WO2014053871A1 (en) 2012-10-04 2014-04-10 INSERM (Institut National de la Santé et de la Recherche Médicale) A method for screening a compound capable of inhibiting the notch1 transcriptional activity
FR3000960B1 (fr) 2013-01-16 2015-03-06 Cisbio Bioassays Nouveaux agents complexants hydrosolubles et complexes de lanthanide correspondants
WO2014136115A1 (en) 2013-03-07 2014-09-12 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Non-selfabsorbing luminescent solar concentrator
FR3004189B1 (fr) 2013-04-04 2015-09-04 Ecole Norm Superieure Lyon Complexes de lanthanide comprenant au moins deux groupes betaines, utiles comme marqueurs luminescents
DE102013113348B4 (de) * 2013-12-02 2017-04-13 Karlheinz Mayer Vorrichtung zum Messen von DNA-Quantenzuständen sowie Verwendung derselben
ES2831014T3 (es) 2014-02-18 2021-06-07 Inst Nat Sante Rech Med Métodos y composiciones farmacéuticas para el tratamiento de enfermedades mediadas por la vía de señalización del complejo NRP-1/OBR
US10189887B2 (en) 2014-04-17 2019-01-29 Inserm (Institut National De La Sante Et De La Recherche Medicale) Polypeptides and uses thereof for reducing CD95-mediated cell motility
FR3032797B1 (fr) 2015-02-13 2017-03-03 Cisbio Bioassays Procede de quantification d'une proteine d'interet presente dans un echantillon biologique
WO2016203119A1 (fr) * 2015-06-17 2016-12-22 Total Sa Methode et solution de dosage d'inhibiteurs dans un fluide petrolier contenant de l'eau
JP6782716B2 (ja) 2015-06-25 2020-11-11 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ 抗体またはリガンドの結合および機能を明らかにするための細胞ベースアッセイ法
FR3045053B1 (fr) 2015-12-09 2018-01-05 Cisbio Bioassays Agents complexants hydrosolubles a base de triazapyridinophane et complexes de lanthanide fluorescents correspondants
US11738321B2 (en) * 2016-06-02 2023-08-29 The Regents Of The University Of California Lanthanide-chelator combinatorial barcoding
WO2018114772A1 (en) 2016-12-21 2018-06-28 F. Hoffmann-La Roche Ag Assay for determining antibody or ligand binding and function
FR3067349B1 (fr) 2017-06-12 2020-12-04 Cisbio Bioassays Nouveaux agents mono et di-antennes complexants hydrosolubles et complexes de lanthanide correspondants
FR3067712B1 (fr) 2017-06-14 2019-08-02 Cisbio Bioassays Nouveaux agents complexants de type trimethoxyphenyl pyridine hydrosolubles et complexes de lanthanide correspondants
FR3069644A1 (fr) 2017-07-28 2019-02-01 Cisbio Bioassays Methode pour mesurer la modulation de l'activation d'un recepteur couple a une proteine g
WO2019059961A1 (en) * 2017-09-25 2019-03-28 California Institute Of Technology BISTABLE POLYNUCLEOTIDE DEVICES FOR DETECTION AND QUANTIFICATION OF MOLECULAR EVENTS
FR3084365B1 (fr) 2018-07-27 2020-10-23 Cisbio Bioassays Anticorps a domaine unique qui se lient a la proteine g alpha
EP3908680B1 (de) 2019-01-11 2023-03-01 Institut National de la Santé et de la Recherche Médicale (INSERM) Verfahren zum screening von inhibitoren gegen das chikungunya-virus und zum bestimmen, ob probanden für eine infektion mit diesem virus prädisponiert sind
FR3092172B1 (fr) 2019-01-30 2021-02-12 Cisbio Bioassays Méthode pour mesurer la modulation de l’activation d’un récepteur couplé à une protéine G avec des analogues du GTP
TW202334089A (zh) 2021-11-02 2023-09-01 美商夫雷爾醫療公司 Ｐｐａｒｇ反向激動劑及其用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4801722A (en) * 1981-07-01 1989-01-31 Eastman Kodak Company Coumarin chelates
US4794191A (en) * 1981-07-01 1988-12-27 Eastman Kodak Company Fluorescent chelates
US4837169A (en) * 1981-07-01 1989-06-06 Eastman Kodak Company Polypyridine Fluorescent labels for immunoassay
US4421654A (en) * 1981-07-01 1983-12-20 Dow Corning Corporation Metal extraction from solution and novel compounds used therefor
US4637988A (en) * 1981-07-01 1987-01-20 Eastman Kodak Company Fluorescent labels for immunoassay
US5021567A (en) * 1987-09-24 1991-06-04 Abbott Laboratories 8-hydroxyquinoline chelating agents
SE8801702D0 (sv) * 1988-05-05 1988-05-05 Pharmacia Ab Sett vid bestemning av enzymatisk aktivitet

Also Published As

Publication number Publication date
DE69535554T2 (de) 2008-04-30
EP0767912B1 (de) 2007-08-08
WO1996000901A1 (en) 1996-01-11
JPH10505820A (ja) 1998-06-09
US5639615A (en) 1997-06-17
CA2193501A1 (en) 1996-01-11
AU2956795A (en) 1996-01-25
CA2193501C (en) 2000-08-08
EP0767912A4 (de) 2001-08-22
US5656433A (en) 1997-08-12
US5622821A (en) 1997-04-22
JP3814291B2 (ja) 2006-08-23
AU688928B2 (en) 1998-03-19
ES2290953T3 (es) 2008-02-16
EP0767912A1 (de) 1997-04-16

Similar Documents

Publication Publication Date Title
DE69535554D1 (de) Lumineszente lanthanidenchelate und verfahren zu ihrer verwendung
DE69521333D1 (de) Reinigungsmittel und verfahren zu dessen verwendung
DE69620902D1 (de) Fluoreszent- und lumineszentmarkierungszusammensetzungen und verfahren zu ihrer verwendung
DE69814891D1 (de) Zusammengesetzte umkehrosmosemembran und verfahren zu ihrer herstellung
DE69023417D1 (de) Anpassungsschaltung und Verfahren zu ihrer Verwendung.
DE69519809D1 (de) Bandulierungssystem und verfahren zu dessen verwendung
DE69737053D1 (de) Chip-Widerstand und Verfahren zu dessen Herstellung
DE69504892D1 (de) Mischelement und Verfahren zu dessen Herstellung
DE69530976D1 (de) Schleifgegenstände und verfahren zu ihrer herstellung
DE69825960D1 (de) In 2-position substituierte 7-haloindene und verfahren zu ihrer herstellung
DE69529493D1 (de) Anzeigevorrichtung und Verfahren zu ihrer Herstellung
DE69824111D1 (de) Führungslenker und Verfahren zu seiner Herstellung
DE69724218D1 (de) Universale feste träger und verfahren zu ihrer verwendung
DE69733416D1 (de) Erythromycine und verfahren zu ihrer herstellung
DE69105793D1 (de) Löt-Polymer-Komposit-Paste und Verfahren zu ihrer Verwendung.
DE59706552D1 (de) Geschoss und Verfahren zu dessen Herstellung
ATE206131T1 (de) Phosphonomonoesternnukleinsäuren, verfahren zu ihrer herstellung und ihre verwendung
DE69529065D1 (de) Härtbare zusammensetzung und verfahren zu ihrer herstellung
DE4491348T1 (de) Orientierbare Führungsgarnitur und Verfahren zu ihrer Verwendung
DE69720807D1 (de) Verändliche graphik und verfahren zu ihrer herstellung und verwendung
DE69511779D1 (de) Lumineszenzdioden-Anordnung und Verfahren zu ihrer Herstellung
DE69524684T2 (de) Photosensor und Verfahren zu dessen Herstellung
DE69502301T2 (de) Ladesystem und Verfahren zu dessen Herstellung
DE69433296D1 (de) Eisen-lactoferrin kombination und verfahren zu ihrer herstellung
DE69510774T2 (de) Katschukzusammensetzung und verfahren zu ihrer herstellung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition